Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1314 | 2017 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 717 | 2021 |
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 354 | 2017 |
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 149 | 2020 |
Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein–DNA complex formation and are associated with height and vitamin D status in … A d'Alésio, M Garabédian, JP Sabatier, G Guaydier-Souquieres, ... Human molecular genetics 14 (22), 3539-3548, 2005 | 76 | 2005 |
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 Y Hamdi, P Soucy, V Adoue, K Michailidou, S Canisius, A Lemacon, ... Oncotarget 7 (49), 80140, 2016 | 43 | 2016 |
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of … Y Hamdi, P Soucy, KB Kuchenbaeker, T Pastinen, A Droit, A Lemaçon, ... Breast cancer research and treatment 161, 117-134, 2017 | 26 | 2017 |
EMBRACE; GEMO Study Collaborators; HEBON; kConFab/AOCS Investigators; and NBSC Collaborators (2017). Identification of ten variants associated with risk of estrogen-receptor … RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nat. Genet 49, 1767-1778, 0 | 18 | |
metagene Profiles Analyses Reveal Regulatory Element’s Factor-Specific Recruitment Patterns C Joly Beauparlant, FC Lamaze, A Deschênes, R Samb, A Lemaçon, ... PLoS computational biology 12 (8), e1004751, 2016 | 14 | 2016 |
A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 13 | 2023 |
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... bioRxiv, 521054, 2019 | 12 | 2019 |
Genetics of symptom remission in outpatients with COVID-19 MP Dubé, A Lemaçon, A Barhdadi, LP Lemieux Perreault, E Oussaïd, ... Scientific Reports 11 (1), 10847, 2021 | 10 | 2021 |
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT MP Dubé, MA Legault, A Lemaçon, LP Lemieux Perreault, R Fouodjio, ... Circulation: Genomic and Precision Medicine 14 (2), e003183, 2021 | 10 | 2021 |
Deep interpretability for GWAS D Sharma, A Durand, MA Legault, LPL Perreault, A Lemaçon, MP Dubé, ... arXiv preprint arXiv:2007.01516, 2020 | 8 | 2020 |
Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women M Sun, A Lemacon, MA Legault, G Asselin, S Provost, H Aschard, ... The Pharmacogenomics Journal 21 (4), 446-457, 2021 | 5 | 2021 |
LD-annot: a bioinformatics tool to automatically provide candidate SNPs with annotations for genetically linked genes J Prunier, A Lemaçon, A Bastien, M Jafarikia, I Porth, C Robert, A Droit Frontiers in Genetics 10, 1192, 2019 | 5 | 2019 |
Uncovering the contribution of moderate-penetrance susceptibility genes to breast cancer by whole-exome sequencing and targeted enrichment sequencing of candidate genes in … M Dumont, N Weber-Lassalle, C Joly-Beauparlant, C Ernst, A Droit, ... Cancers 14 (14), 3363, 2022 | 4 | 2022 |
DSNetwork: An integrative approach to visualize predictions of variants’ deleteriousness A Lemaçon, MP Scott-Boyer, R Ongaro-Carcy, P Soucy, J Simard, A Droit Frontiers in Genetics 10, 500588, 2020 | 4 | 2020 |
VEXOR: an integrative environment for prioritization of functional variants in fine-mapping analysis A Lemaçon, C Joly Beauparlant, P Soucy, J Allen, D Easton, P Kraft, ... Bioinformatics 33 (9), 1389-1391, 2017 | 3 | 2017 |
Pharmacogenomic study of heart failure and candesartan response from the CHARM programme MP Dubé, O Chazara, A Lemaçon, G Asselin, S Provost, A Barhdadi, ... ESC Heart Failure 9 (5), 2997-3008, 2022 | 2 | 2022 |